Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorien Autaers

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 17, 2017
Evaluation of the Copan Myco-TB kit for the decontamination of respiratory samples for the detection of MycobacteriaDeborah De Geyter, Danny Cnudde, Mieke Van der Beken, et al.
Molecular Therapy. Nucleic Acids|July 17, 2025
Sequence simplification of antigen coding IVT mRNA allows accelerated synthetic DNA template generation and epitope immunogenicity validationArthur Esprit, Dorien Autaers, Ilke Aernout, et al.
Frontiers in Immunology|June 19, 2025
An mRNA-based workflow validating neo-epitope presentation through HLA-I/peptide affinity purificationArthur Esprit, Dorien Autaers, Kris Thielemans, et al.
Frontiers in Immunology|March 2, 2023
An mRNA mix redirects dendritic cells towards an antiviral program, inducing anticancer cytotoxic stem cell and central memory CD8<sup>+</sup> T cellsWout de Mey, Hanne Locy, Kirsten De Ridder, et al.
Molecular Therapy. Nucleic Acids|September 26, 2022
A synthetic DNA template for fast manufacturing of versatile single epitope mRNAWout de Mey, Phaedra De Schrijver, Dorien Autaers, et al.
Biomolecules|April 30, 2021
Overcoming the Challenges of High Quality RNA Extraction from Core Needle BiopsyHanne Locy, Rohann J M Correa, Dorien Autaers, et al.
Molecular Therapy. Oncology|December 11, 2025
Preclinical development and selection of nanobody-based CAR-T cells targeting HER2-positive solid tumorsFien Meeus, Arne Van der Vreken, Dorien Autaers, et al.
Journal for Immunotherapy of Cancer|November 19, 2024
Preclinical evaluation of antigen-sensitive B7-H3-targeting nanobody-based CAR-T cells in glioblastoma cautions for on-target, off-tumor toxicityFien Meeus, Cyprine Neba Funeh, Robin Maximilian Awad, et al.
Journal of Hematology & Oncology|November 14, 2025
B7-H3 nanobody-based CAR T cells control multiple myeloma growth, while dual BCMA/B7-H3 CAR T cells overcome antigen escapeArne Van der Vreken, Fien Meeus, Chenggong Tu, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 17, 2017
Evaluation of the Copan Myco-TB kit for the decontamination of respiratory samples for the detection of MycobacteriaDeborah De Geyter, Danny Cnudde, Mieke Van der Beken, et al.
Molecular Therapy. Nucleic Acids|July 17, 2025
Sequence simplification of antigen coding IVT mRNA allows accelerated synthetic DNA template generation and epitope immunogenicity validationArthur Esprit, Dorien Autaers, Ilke Aernout, et al.
Frontiers in Immunology|June 19, 2025
An mRNA-based workflow validating neo-epitope presentation through HLA-I/peptide affinity purificationArthur Esprit, Dorien Autaers, Kris Thielemans, et al.
Frontiers in Immunology|March 2, 2023
An mRNA mix redirects dendritic cells towards an antiviral program, inducing anticancer cytotoxic stem cell and central memory CD8<sup>+</sup> T cellsWout de Mey, Hanne Locy, Kirsten De Ridder, et al.
Molecular Therapy. Nucleic Acids|September 26, 2022
A synthetic DNA template for fast manufacturing of versatile single epitope mRNAWout de Mey, Phaedra De Schrijver, Dorien Autaers, et al.
Biomolecules|April 30, 2021
Overcoming the Challenges of High Quality RNA Extraction from Core Needle BiopsyHanne Locy, Rohann J M Correa, Dorien Autaers, et al.
Molecular Therapy. Oncology|December 11, 2025
Preclinical development and selection of nanobody-based CAR-T cells targeting HER2-positive solid tumorsFien Meeus, Arne Van der Vreken, Dorien Autaers, et al.
Journal for Immunotherapy of Cancer|November 19, 2024
Preclinical evaluation of antigen-sensitive B7-H3-targeting nanobody-based CAR-T cells in glioblastoma cautions for on-target, off-tumor toxicityFien Meeus, Cyprine Neba Funeh, Robin Maximilian Awad, et al.
Journal of Hematology & Oncology|November 14, 2025
B7-H3 nanobody-based CAR T cells control multiple myeloma growth, while dual BCMA/B7-H3 CAR T cells overcome antigen escapeArne Van der Vreken, Fien Meeus, Chenggong Tu, et al.
Pageof 1